PMC:28985 / 6944-7381 JSONTXT

{"project":"2_test","denotations":[{"id":"11056693-1548948-23615915","span":{"begin":205,"end":207},"obj":"1548948"},{"id":"11056693-3132866-23615916","span":{"begin":433,"end":435},"obj":"3132866"}],"text":"Midazolam\nIn one study of ICU patients receiving midazolam, alpha frequency decreased and beta activity became prominent. In higher doses, these changes disappeared to be replaced by delta/theta activity [10]. The onset of action and recovery following intravenous administration of midazolam is rapid. When administered to counteract sedative effect, the benzodiazepine antagonist flumazinil quickly normalizes alpha wave activity [11]."}

{"project":"Colil","denotations":[{"id":"T6","span":{"begin":205,"end":207},"obj":"1548948"},{"id":"T7","span":{"begin":433,"end":435},"obj":"3132866"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/docs/sourcedb/PubMed/sourceid/"}],"text":"Midazolam\nIn one study of ICU patients receiving midazolam, alpha frequency decreased and beta activity became prominent. In higher doses, these changes disappeared to be replaced by delta/theta activity [10]. The onset of action and recovery following intravenous administration of midazolam is rapid. When administered to counteract sedative effect, the benzodiazepine antagonist flumazinil quickly normalizes alpha wave activity [11]."}